Retrobradykinin has the reverse sequence of Bradykinin. Retrobradykinin has no significant kinin activity and can be used as a negative control for Bradykinin.
MEN 11270, a cyclic decapeptide, is a B2 kinin receptor antagonist. MEN 11270 bound with high-affinity to the B2 kinin receptor constitutively expressed by WI38 human fibroblasts, inhibiting 3H-bradykinin (BK) with pKi of 10.3.
Deucrictibant is a potent bradykinin receptor antagonist. Bradykinin receptors are cell surface, G-protein coupled receptors of the seven-transmembrane domained family.
Get Quote
X
We have received your inquiry regarding and will respond to you as soon as possible.